Targeted Delivery of siRNA
暂无分享,去创建一个
[1] A. Lee,et al. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[2] B. Bosch,et al. Soluble Receptor-Mediated Targeting of Mouse Hepatitis Coronavirus to the Human Epidermal Growth Factor Receptor , 2005, Journal of Virology.
[3] Qi Zhou,et al. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. , 2005, Human gene therapy.
[4] Satoshi Gojo,et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. , 2005, Biochemical and biophysical research communications.
[5] Hongtao Liao,et al. Biomembrane-permeable and Ribonuclease-resistant siRNA with enhanced activity. , 2005, Oligonucleotides.
[6] Y. Omidi,et al. Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology. , 2005, Current drug delivery.
[7] M. Gottesman,et al. Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirions. , 2005, Human Gene Therapy.
[8] Peixuan Guo,et al. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. , 2005, Human gene therapy.
[9] Phillip D. Zamore,et al. Ribo-gnome: The Big World of Small RNAs , 2005, Science.
[10] T. Ochiya,et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Seppen,et al. persistent knockdown of CCR2 function in vivo Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to , 2013 .
[12] M. Woodle,et al. In Vivo Application of RNA Interference: From Functional Genomics to Therapeutics , 2005, Advances in Genetics.
[13] A. J. Mixson,et al. Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo , 2005, Cancer Gene Therapy.
[14] P. J. Welch,et al. State-of-the-art modified RNAi compounds for therapeutics. , 2005, IDrugs : the investigational drugs journal.
[15] Richard W. Carthew,et al. Silence from within: Endogenous siRNAs and miRNAs , 2005, Cell.
[16] M. Sioud. On the delivery of small interfering RNAs into mammalian cells , 2005, Expert opinion on drug delivery.
[17] Hideyoshi Harashima,et al. RNA interference induced by siRNAs modified with 4′‐thioribonucleosides in cultured mammalian cells , 2005, FEBS letters.
[18] Gregory J. Hannon,et al. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies , 2005, Nature Cell Biology.
[19] S. Ashley,et al. RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells. , 2005, Biochemical and biophysical research communications.
[20] Judy Lieberman,et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.
[21] B. Polisky,et al. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication , 2005, Hepatology.
[22] R. Griffey,et al. Positional effect of chemical modifications on short interference RNA activity in mammalian cells. , 2005, Journal of Medicinal Chemistry.
[23] H. Blau,et al. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies , 2005, Nature Cell Biology.
[24] M. Sioud. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. , 2005, Journal of molecular biology.
[25] F. He,et al. Cationic lipids enhance siRNA-mediated interferon response in mice. , 2005, Biochemical and biophysical research communications.
[26] L. Greensmith,et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model , 2005, Nature Medicine.
[27] I. Ahmad,et al. Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. , 2005, International journal of oncology.
[28] R. Schiffelers,et al. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. , 2005, Arthritis and rheumatism.
[29] C. Boshoff,et al. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. , 2005, Blood.
[30] C. Henderson,et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS , 2005, Nature Medicine.
[31] A. Aigner,et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo , 2005, Gene Therapy.
[32] G. Nolan,et al. Gene therapy progress and prospects: Novel gene therapy approaches for AIDS , 2005, Gene Therapy.
[33] S. Akira,et al. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.
[34] D. Palmer,et al. Helper-dependent adenoviral vectors for gene therapy. , 2005, Human gene therapy.
[35] Qun Zhou,et al. Viral vectors for cancer gene therapy: viral dissemination and tumor targeting. , 2005, Current gene therapy.
[36] Sung Ho Hahm,et al. Retroviral gene therapy: safety issues and possible solutions. , 2005, Current gene therapy.
[37] F. Chisari,et al. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] T. Rana,et al. Specific and potent RNAi in the nucleus of human cells , 2005, Nature Structural &Molecular Biology.
[39] F. Porreca,et al. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons , 2005, Molecular pain.
[40] W. Denk,et al. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Manoharan. RNA interference and chemically modified small interfering RNAs. , 2004, Current opinion in chemical biology.
[42] Raymond M Schiffelers,et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. , 2004, The American journal of pathology.
[43] Matthias John,et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.
[44] S. Chae,et al. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. , 2004, The Journal of clinical investigation.
[45] J. Lieberman,et al. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Ashley,et al. Systemic siRNA-Mediated Gene Silencing: A New Approach to Targeted Therapy of Cancer , 2004, Annals of surgery.
[47] T. Rana,et al. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.
[48] K. Taira,et al. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[49] Y. Yuzawa,et al. A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics , 2004, Cancer Research.
[50] Anton P. McCaffrey,et al. In vivo activity of nuclease-resistant siRNAs. , 2004, RNA.
[51] M. Eccles,et al. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells , 2004, FEBS letters.
[52] E. H. Feinberg,et al. Transport of dsRNA into Cells by the Transmembrane Protein SID-1 , 2003, Science.
[53] T. Rana,et al. siRNA function in RNAi: a chemical modification analysis. , 2003, RNA.
[54] Robert H. Silverman,et al. Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.
[55] David R Corey,et al. RNA interference in mammalian cells by chemically-modified RNA. , 2003, Biochemistry.
[56] A. Klippel,et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. , 2003, Nucleic acids research.
[57] Mouldy Sioud,et al. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. , 2003, Journal of molecular biology.
[58] Thomas Tuschl,et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. , 2003, Antisense & nucleic acid drug development.
[59] Jens Kurreck,et al. Antisense technologies. Improvement through novel chemical modifications. , 2003, European journal of biochemistry.
[60] P. Monahan,et al. Safety of adeno-associated virus gene therapy vectors: a current evaluation , 2002, Expert opinion on drug safety.
[61] J. Kappes,et al. Safety Considerations in Vector Development , 2001, Somatic cell and molecular genetics.
[62] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[63] S. Gambhir,et al. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[64] J. Wilschut,et al. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs , 2006, Gene Therapy.
[65] Tadaharu Tsumoto,et al. RNAi-induced gene silencing by local electroporation in targeting brain region. , 2005, Journal of neurophysiology.
[66] H. Mizuguchi,et al. Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference , 2005, Gene Therapy.
[67] Raymond M. Schiffelers,et al. Pharmaceutical Prospects for RNA Interference , 2004, Pharmaceutical Research.
[68] R. Schiffelers,et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.
[69] K. Alexander,et al. RNA interference using boranophosphate siRNAs: structure-activity relationships. , 2004, Nucleic acids research.
[70] N. Kosaka,et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. , 2004, Nucleic acids research.
[71] M. Famulok,et al. Functional tuning of nucleic acids by chemical modifications: tailored oligonucleotides as drugs, devices, and diagnostics. , 2003, Chemical record.
[72] J. Dausset,et al. Journal of Biomedicine and Biotechnology , 2001, Journal of biomedicine & biotechnology.